JP2008507298A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507298A5
JP2008507298A5 JP2007527427A JP2007527427A JP2008507298A5 JP 2008507298 A5 JP2008507298 A5 JP 2008507298A5 JP 2007527427 A JP2007527427 A JP 2007527427A JP 2007527427 A JP2007527427 A JP 2007527427A JP 2008507298 A5 JP2008507298 A5 JP 2008507298A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
conjugate
sequence
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007527427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507298A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/017471 external-priority patent/WO2005113592A2/en
Publication of JP2008507298A publication Critical patent/JP2008507298A/ja
Publication of JP2008507298A5 publication Critical patent/JP2008507298A5/ja
Pending legal-status Critical Current

Links

JP2007527427A 2004-05-19 2005-05-18 インターフェロンαポリペプチドおよび結合体 Pending JP2008507298A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57250404P 2004-05-19 2004-05-19
PCT/US2005/017471 WO2005113592A2 (en) 2004-05-19 2005-05-18 Interferon-alpha polypeptides and conjugates

Publications (2)

Publication Number Publication Date
JP2008507298A JP2008507298A (ja) 2008-03-13
JP2008507298A5 true JP2008507298A5 (https=) 2008-07-10

Family

ID=35428915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527427A Pending JP2008507298A (ja) 2004-05-19 2005-05-18 インターフェロンαポリペプチドおよび結合体

Country Status (14)

Country Link
US (9) US7318918B2 (https=)
EP (1) EP1753779A2 (https=)
JP (1) JP2008507298A (https=)
CN (1) CN101115769A (https=)
AR (1) AR049177A1 (https=)
AU (1) AU2005245918A1 (https=)
BR (1) BRPI0511196A (https=)
CA (1) CA2566247A1 (https=)
IL (1) IL178470A0 (https=)
MX (1) MXPA06013412A (https=)
NO (1) NO20065084L (https=)
RU (1) RU2006145020A (https=)
TW (1) TW200611910A (https=)
WO (1) WO2005113592A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360011A1 (en) 1999-01-05 2000-07-13 Trustees Of Boston University Ordered gene assembly
US20040005673A1 (en) 2001-06-29 2004-01-08 Kevin Jarrell System for manipulating nucleic acids
AU2001277014A1 (en) * 2000-07-21 2002-02-05 Trustees Of Boston University Modular vector systems
US7435562B2 (en) 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
JP2008500750A (ja) * 2004-05-12 2008-01-10 フュージョンワン インコーポレイテッド 高度な連絡先識別システム
WO2006053131A1 (en) 2004-11-11 2006-05-18 Modular Genetics, Inc. Ladder assembly and system for generating diversity
AU2006257286B2 (en) * 2005-03-09 2012-08-16 Superlab Far East Limited Uses of recombinant super-compound interferons
EP1888633A4 (en) 2005-05-18 2010-01-27 Maxygen Inc UNFOLDED INTERFERON ALPHA POLYPEPTIDE
AR078117A1 (es) * 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
US20080014616A1 (en) * 2006-07-11 2008-01-17 Kevin Jarrell Methods of introducing targeted diversity into nucleic acid molecules
WO2008013082A1 (en) * 2006-07-25 2008-01-31 Galpharma Co., Ltd. Galectin 9-polymer conjugate
US7808342B2 (en) * 2006-10-02 2010-10-05 Skyworks Solutions, Inc. Harmonic phase tuning filter for RF switches
WO2008124086A2 (en) 2007-04-05 2008-10-16 President And Fellows Of Harvard College Chimeric activators: quantitatively designed protein therapeutics and uses thereof
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
WO2009006579A1 (en) * 2007-07-05 2009-01-08 Pharmaessentia Corp. Peptide-polymer conjugates
WO2009046080A1 (en) 2007-10-01 2009-04-09 Pharmaessentia Corp. N-terminal modified interferon-alpha
KR20100103595A (ko) * 2008-01-18 2010-09-27 에프. 호프만-라 로슈 아게 비-글라이코실화된 단백질의 정제
US7954022B2 (en) * 2008-01-30 2011-05-31 Alcatel-Lucent Usa Inc. Apparatus and method for controlling dynamic modification of a scan path
MX2011005051A (es) * 2008-11-17 2011-06-01 Genentech Inc Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas.
WO2010087994A2 (en) 2009-01-30 2010-08-05 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
US9944688B2 (en) 2011-06-02 2018-04-17 Hanmi Science Co., Ltd. Non-peptidyl polymer-insulin multimer and method for producing the same
AU2012275390A1 (en) 2011-06-28 2014-01-16 Whitehead Institute For Biomedical Research Using sortases to install click chemistry handles for protein ligation
CN102358897B (zh) * 2011-10-31 2013-02-13 北京三元基因工程有限公司 重组人寡腺苷酸合成酶-1的制备方法
WO2015168474A1 (en) * 2014-04-30 2015-11-05 President And Fellows Of Harvard College Fusion proteins for treating cancer and related methods
ES2630106T3 (es) * 2014-10-07 2017-08-18 Cyprumed Gmbh Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos
CN115400220A (zh) 2015-12-30 2022-11-29 豪夫迈·罗氏有限公司 减少聚山梨酯降解的制剂
CN116769054A (zh) * 2016-02-05 2023-09-19 奥里尼斯生物科学私人有限公司 双特异性信号传导剂及其用途
RU2650755C1 (ru) * 2017-05-24 2018-04-17 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки лекарственного средства пролонгированного действия на основе рекомбинантного аналога интерферона альфа-17 для лечения вирусного гепатита С
EP4093755A4 (en) * 2020-01-24 2024-07-31 Alkermes Pharma Ireland Limited PURIFICATION PROCESSES

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610830B1 (en) * 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
ES506955A0 (es) 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
WO1983002461A1 (en) 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPS60152058A (ja) * 1984-01-20 1985-08-10 Toshiba Corp 半導体記憶装置
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US4695626A (en) * 1986-07-29 1987-09-22 Pfizer Inc. 1-aza-4,5-dithiabicyclo [4.2.0] oct-2-en-8-one-2 carboxylate esters
AU660633B2 (en) 1990-10-17 1995-07-06 Amgen, Inc. Methods and compositions for the treatment of cell proliferation disorders
US5372808A (en) 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5595732A (en) * 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5574138A (en) * 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
PT741577E (pt) 1994-03-07 2003-03-31 Imperial College Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
ES2297889T3 (es) 1997-07-14 2008-05-01 Bolder Biotechnology, Inc. Derivados de hormona de crecimiento y proteinas relacionadas.
CA2359345A1 (en) 1999-01-14 2000-07-20 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
AU3725600A (en) * 1999-03-02 2000-09-21 Maxygen, Inc. Surrogate orphan ligands for orphan receptors
RU2262510C9 (ru) 1999-05-19 2006-04-20 Лексиген Фармасьютикэлс Корп. Слитый белок, обладающий биологической активностью интерферона-альфа, димерный слитый белок, фармацевтическая композиция, их содержащая, молекула днк (варианты) и способ адресования интерферона-альфа в ткани печени
WO2001025438A2 (en) 1999-10-07 2001-04-12 Maxygen, Inc. Ifn-alpha homologues
US20040002474A1 (en) * 1999-10-07 2004-01-01 Maxygen Inc. IFN-alpha homologues
CA2390292A1 (en) * 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
WO2002044197A2 (en) 2000-12-01 2002-06-06 Fish Eleanor N Cytokine receptor binding peptides
KR100459105B1 (ko) 2001-02-15 2004-12-03 선바이오(주) 변형된 인터페론-알파 2ａ 및 2ｂ, 그리고 이들과 ＰＥＧ유도체와의 배합체
ATE337017T1 (de) * 2002-11-15 2006-09-15 Hoffmann La Roche Positionelle isomeren von pegyliertem interferon alpha 2a
EP1565205A4 (en) * 2002-11-18 2006-07-05 Maxygen Inc Interferon-alpha polypeptides and conjugates

Similar Documents

Publication Publication Date Title
JP2008507298A5 (https=)
JP2008505985A5 (https=)
RU2006145020A (ru) Полипептиды и конъюгаты интерферона-альфа
JP6297969B2 (ja) 部位特異的モノｐｅｇ化エキセンジン類似体およびその調製方法
CN101595122B (zh) 长效多肽及其生产和施用方法
CN103443122B (zh) 人胰岛素类似物及其酰化衍生物
EP3998077B1 (en) Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
JP2001520238A5 (https=)
JP6325585B2 (ja) インターロイキン−２２のウイルス性肝炎の治療における応用
CN102171249A (zh) 长效干扰素及其衍生物以及其方法
JPH07509228A (ja) 副甲状腺ホルモンおよび副甲状腺ホルモン関連ペプチドの類似体：それらの合成および骨粗鬆症の処置のための用途
JP2006506097A5 (https=)
RU2005118998A (ru) Полипептиды и конъюгаты альфа-интерферона
CN102558362A (zh) 一种用于治疗糖尿病的融合蛋白及其制备方法
JP2008545393A5 (https=)
CN108864292B (zh) 一种干扰素重组融合蛋白及其应用
CN106279430B (zh) Exendin‑4类似物融合蛋白及其制备方法和用途
ES2290156T3 (es) Vector de expresion y secrecion del alfa interferon humano y procedimiento para producir alfa interferon humano empleando el anterior.
JPH0338600A (ja) Ｖｉｐ同族体
RU2575796C9 (ru) Пегилированный конъюгат варианта рекомбинантного консенсусного интерферона и способ его получения, и применение
RU2575796C2 (ru) Пегилированный конъюгат варианта рекомбинантного консенсусного интерферона и способ его получения, и применение
CN105085658B (zh) 一种白细胞介素29突变体及聚乙二醇衍生物
JP2011521648A5 (https=)
CN101671390B (zh) 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途
ES2657788T3 (es) Proteínas fusionadas de interferón alfa 5 con otra citocina y un proceso de producción de las mismas